Previous studies have also proven that borneol can improve radiotherapy efficacy in glioma, and its mechanism might be related to the downregulation of hypoxia inducible factor-1 (HIF-1α) expression (Wang et al., 2020b; Qinglin et al., 2021). Here, HIF1A is linked to central nervous system cancer.